Having explored the earlier segments of the patient pathway, our next set of episodes will focus on injectable therapies, and how and when to advance to these. Join Dr Vanita Aroda for an overview of initial choices in injectable therapy, including basal insulin and fixed ratio combiantions of GLP-1 RA and insulin.

References

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education